Sino Medical Sciences Technology Inc. Class A

As of June 30, 2026, Sino Medical Sciences Technology Inc. Class A carries a market capitalization of 7.74B, placing it among publicly traded companies globally. Its enterprise value stands at 7.54B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Sino Medical Sciences Technology Inc. Class A's next confirmed earnings release is scheduled for October 31, 2026.

As of June 30, 2026, Sino Medical Sciences Technology Inc. Class A has 417.95M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Sino Medical Sciences Technology Inc. Class A maintains a current ratio of 2.66, meaning it holds 2.7x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Sino Medical Sciences Technology Inc. Class A recorded 19.77M in income tax expense.

As of the close on October 22, 2026, Sino Medical Sciences Technology Inc. Class A's stock has declined approximately 52.67% over the past 52 weeks. The 50-day moving average sits at 16.20, while the 200-day moving average is 19.49.

As of June 30, 2026, Sino Medical Sciences Technology Inc. Class A holds 430.32M in cash and equivalents against 151.32M in total debt, resulting in a net debt position of -301.42M. Total book value stands at 997.23M, with working capital of 356.42M providing operational flexibility.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Sino Medical Sciences Technology Inc. Class A paid dividends of 0.01 per share.